Previously, we found that ABL kinases are activated by receptor tyrosine kinases such as EGFR, PDGFR, and IGF1R [26,27,28], and BRAF contributes to ABL1/2 activation in melanoma cells harboring BRAF-V600E [22]. The gene discussed is ABL1; the disease is melanoma.